This Article Full Text Full Text (PDF) All Versions of this Article: 28/2/233    most recent ATVBAHA.107.141606v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Crawley, J. T.B. Articles by Lane, D. A. Search for Related Content PubMed PubMed Citation Articles by Crawley, J. T.B. Articles by Lane, D. A. Related Collections Related Article

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:233.)
© 2008 American Heart Association, Inc.

Brief Review

The Haemostatic Role of Tissue Factor Pathway Inhibitor

James T.B. Crawley; David A. Lane

From the Department of Hematology, Imperial College London, UK.

Correspondence to James T.B. Crawley, Department of Hematology, Imperial College London, 5th Floor Commonwealth Building, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. E-mail j.crawley{at}imperial.ac.uk

Under normal conditions the blood circulates freely within the confines of the vascular system, carrying oxygen, nutrients, and hormonal information around the body and removing metabolic waste. If blood gains access to extravascular sites, or the vasculature becomes pathologically challenged, hemostasis may be activated. This process is finely regulated by positive and negative feedback loops that modulate fibrin clot formation. Blood coagulation revolves around the activation and assembly of the components of the prothrombinase complex, which converts the inactive zymogen, prothrombin, into its active form, thrombin. This serine protease catalyzes the conversion of fibrinogen to fibrin, the structural scaffold that stabilizes platelet aggregates at sites of vascular injury. The extent of the hemostatic response is controlled by the action of inhibitory pathways, which ensure that thrombin activity and the spread of the hemostatic plug is limited to the site of vessel damage. This review article focuses on the major physiological regulator of tissue factor–induced coagulation, tissue factor pathway inhibitor, its expression, anticoagulant function, and its role in normal hemostasis.

Key Words: TFPI • anticoagulant • tissue factor • thrombosis • hemostasis

Related Article:

Adding Complexity to Fibronectin-Platelet Interactions

Deane F. Mosher
Arterioscler. Thromb. Vasc. Biol. 2008 28: 203-204. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				F. Xu, M. L. Previti, M. T. Nieman, J. Davis, A. H. Schmaier, and W. E. Van Nostrand A{beta}PP/APLP2 Family of Kunitz Serine Proteinase Inhibitors Regulate Cerebral Thrombosis J. Neurosci., April 29, 2009; 29(17): 5666 - 5670. [Abstract] [Full Text] [PDF]

				C. Duckers, P. Simioni, L. Spiezia, C. Radu, S. Gavasso, J. Rosing, and E. Castoldi Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency Blood, November 1, 2008; 112(9): 3615 - 3623. [Abstract] [Full Text] [PDF]